GPs are reminded of the risk of potentially fatal neutropenia and agranulocytosis with the use of clozapine

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1027, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clozapine: Neutropenia and agranulocytosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Clozapine: Fatal agranulocytosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1094, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Clozapine: Agranulocytosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1133, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Clozapine/valproic acid/risperidone interaction: Increased neutropenia risk: case report

By  

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Clozapine: Agranulocytosis: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1319, 2010-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite